A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)

NCT00183963 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Insufficient accrual

Conditions

Breast Carcinoma

Interventions

DRUG: Tamoxifen
DRUG: Fulvestrant
DRUG: Fulvestrant

Sponsor

University of Southern California

Collaborators

[object Object]